Chronic Pain Is Not Just a Symptom. It Is a Systems Problem.

Chronic pain is often described as a symptom. But for many people, it becomes something larger, a system that reshapes daily life. It can change how someone walks, sleeps, works, exercises, parents, travels, and participates in the world. It can alter mood, reduce independence, limit mobility, and create a cycle where discomfort leads to less movement, less movement leads to more weakness, and the body becomes harder to restore.

CDC's National Center for Health Statistics reported that in 2023, 24.3% of U.S. adults had chronic pain, and 8.5% had high-impact chronic pain that frequently limited life or work activities.

The future of pain care will likely focus more on function. That means asking not only whether something hurts less, but whether the person can move better, sleep better, return to work, stay active, participate in physical therapy, avoid unnecessary escalation, and recover with more confidence.

Bioelectric medicine explores whether therapeutic modulation of electrical signaling systems can support future approaches to pain, recovery, and other biological domains. For Electrome, the first commercial focus is practical and grounded, FDA cleared bioelectric therapy technologies for pain and recovery applications. But the larger platform thesis is broader, building toward a system that connects therapeutic devices, patient engagement, provider workflows, real world outcomes, and AI assisted signal intelligence.